Alexandra Murphy
Japan exempts generics from baseline 15% tariff: 4 updates
As part of a new trade agreement with the U.S., Japan is exempting generic pharmaceuticals, their ingredients and chemical precursors from the 15% baseline tariff applied to nearly all other U.S. imports. Here are four tariff updates: Under the agreement with the U.S., Japan will not apply the new 15%…
Read MoreAI tool accelerates leukemia diagnosis: What to know
A team of researchers from University of Florida Health has developed an open-access AI tool to accelerate the diagnosis of acute leukemias, according to a study published July 29 in Nature Communications. The Acute Leukemia Methylome Atlas, or ALMA, maps specific DNA tags called methylation patterns to determine specific leukemia…
Read MoreWhat 17 leaders wish medical students learned about cancer care
As the medical school landscape shifts in response to federal pressures and new demands in the healthcare space — such as technological advancements, AI and drug innovations — new physicians may be entering the field with gaps in their clinical education and personal development. From accepting mortality to supporting survivorship,…
Read MoreOzempic manufacturer to cut 9,000 roles
Novo Nordisk, the Denmark-based manufacturer of Ozempic, said Sept. 10 it plans to reduce approximately 9,000 of its 78,400 global roles. The drugmaker said in a news release the workforce reductions will save 8 billion Danish Krone, or about $1 billion, by the end of 2026. Around 5,000 of the…
Read MoreDHL targets specialty pharmacies, radiopharmacies in deal
DHL Supply Chain is acquiring SDS Rx, a U.S.-based provider of final-mile delivery and specialized transportation services for long-term care and specialty pharmacies, radiopharmacies and health system networks. The deal will expand DHL’s healthcare logistics capabilities, especially in time-critical and same-day delivery services for life sciences and healthcare sectors, according…
Read MoreTrump administration eyes crackdown on Chinese drugs
The Trump administration is weighing the imposition of severe restrictions on medicines from China that, if enacted, could sow “chaos” in the U.S. pharmaceutical industry, especially generics, The New York Times reported Sept. 10. At the center of the proposed crackdown is a draft executive order that would block U.S.…
Read MoreUniversity Hospitals to deploy conversational AI agents
University Hospitals in Cleveland is teaming up with generative AI company Hippocratic AI to deploy conversational agents aimed at improving patient support and clinical workflows. The partnership, announced in a Sept. 10 news release, will focus on using Hippocratic AI’s voice-based agents to expand patient engagement and close care gaps,…
Read MoreHow health systems are navigating financial headwinds: A Q&A with Cecelia Moore and Greg Hoffman
Healthcare executives today face a rapidly evolving policy and economic environment, marked by reimbursement reforms, research funding cuts, and inflationary pressures. As health systems prepare for the next 12 to 18 months, leaders are weighing difficult trade-offs while seeking innovative ways to sustain operations and deliver high-quality care. In a…
Read MoreTrinity Health taps 2 execs for operations
Livonia, Mich.-based Trinity Health has appointed two leaders, a COO and an associate COO, as part of a strategic operational realignment, according to a Sept. 10 news release shared with Becker’s. Dan Roth, MD, executive vice president and chief clinical and community division operations officer, will succeed Ben Carter as…
Read More‘No such thing as too young to have cancer’: NYU Langone on early-onset trend
Between 2010 and 2019, incidence rates of 14 cancers increased among individuals younger than 50, with “concerning increases” reported in colorectal and uterine cancer mortality. While the statistics may raise alarm, one oncology expert is encouraging healthcare leaders to understand the full picture. Mary Gemignani, MD, is chief of the…
Read More